300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
South Korea
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Enterprise Ventures, VC Fund

Enterprise Ventures

VC Fund

Preston, United Kingdom

Enterprise Ventures (EV) is a leading providers of venture capital and early stage finance to SMEs in England and Wales, and one of the few able to provide both equity and debt funding.EV has a wide range of investment funds which it manages on behalf of investor clients from both the private and public sector. It invests sums of up to£2million in businesses at all stages of development, from pre-revenue & proof of concept, through to MBO/MBI opportunities and development and replacement capital.EV is regulated by the Financial Services Authority (FSA) and are full members of the British Venture Capital Association (BVCA).

Total investments:
16
Last investment:
Lead investor:
25%

Last updated:

Industries Enterprise Ventures invests in

BiotechnologyHealth CareMedicalSoftwareBiopharma

Stages Enterprise Ventures invests in

Funding RoundSeedPost-IPO EquitySeries A

Countries Enterprise Ventures invests in

United Kingdom

Round sizes

Post-IPO Equity $524k–$5.1M

Contacts

NameEmailPhoneSocials
See all 12 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Post-IPO Equity
$524k–$5.1M

Investment Focus

Industry

  • Biotechnology 4 (25%)
  • Health Care 3 (19%)
  • Medical 2 (13%)
  • Software 2 (13%)
  • Biopharma 2 (13%)
See all 26 industries →

Stage

  • Funding Round 10 (63%)
  • Seed 2 (13%)
  • Post-IPO Equity 2 (13%)
  • Series A 1 (6%)

Team

NameTitleInvestmentsLinksEmail
Ashwin Kumaraswamy
Ashwin Kumaraswamy Investment Manager
Investment Manager Total investments: 4
Find email
Clive Downward
Clive Downward Investment Director
Investment Director Total investments: 0
Find email
Grahame Lunt
Grahame Lunt Investment Manager
Investment Manager Total investments: 1 Find email
Ian Atkinson
Ian Atkinson Investment Manager
Investment Manager Total investments: 0 Find email
John Simpson
John Simpson Finance Director
Finance Director Total investments: 0 Find email
See all 12 team members →

Investments

CompanyDescriptionRoundLinks
Their products manage a plant’s natural responses to stress factors to build its resilience. This boost in strength helps the plant to flourish in good conditions but also when faced with increasingly common stresses such as heat, salinity, drought and the application of other chemicals.Their head office and primary research facility are at theRothamsted Centre for Research and Enterprise (RoCRE) in Harpenden, UK and they have additional offices in Brazil, USA and Argentina as well as colleagues based in Turkey and France. $5.1M / Post-IPO Equity / Aug 23, 2017
Blue-i Event Technology specialising in the supply of Audio Visual Services to the events industry. Jun 21, 2016
Concepta PLC is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. $524K / Post-IPO Equity / May 09, 2016
Woodall Nicholson is one of the oldest established coachbuilding companies in the UK, dating right back to the 1820′s, when its major market was the building of horse-drawn hansom cabs and carriages. Jul 19, 2013
Xeros Ltd. is a new company focused on the development of "virtually waterless" laundry cleaning. Harnessing over 30 years of research by Professor Stephen Burkinshaw and the University of Leeds, Xeros is the brand name for a patented polymer based cleaning that creates step change advantage in the cost and environmental impact of aqueouswash cleaning. $13.1M / Mar 13, 2013
TyresOnTheDrive is a mobile tyre-fitting company that allows customers to book online or over the phone and have new tyres fitted, or punctures repaired, at any suitable location of their choice, whether that's at home, at work or even at the gym! They’re proud to be different: they’ve long believed that the purchase and fitting of tyresdoesn’t have to be a drawn out, inconvenient and laborious process where the customer has to fit around the static hours of a garage.Their mobile fitting units make sitting around in a cold garage a thing of the past. Now you can be at home or at a work getting on with the things that are important to you, while their expert technicians deal with your tyre fitting. $815K / Feb 06, 2013
Peckforton Pharmaceuticals Ltd. is a fast growing, dynamic speciality pharmaceutical company that manufactures, distributes and sells prescription and OTC products in the UK and Europe.The company is focused into two divisions, Branded and Hospital. Each division has distinct and separate requirements to support both the patient and the healthcareprofessional, with the primary focus on ensuring and maintaining the ‘quality of supply’ and the ‘quality of medicine’. $1.3M / Mar 02, 2012
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories,research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom. $1.7M / Jan 01, 2012
Altacor develops and brings to market specialist ophthalmic products designed for the needs of both ophthalmologists and patients.Altacor brings together skills in drug development with in-depth market knowledge and an understanding of the European regulatory environment, to create a portfolio of high quality, differentiated prescriptionmedicines that set new standards in the sector.Altacor's pipeline includes products for dry-eye, glaucoma, glaucoma surgery and ocular surgery. $2.4M / Feb 09, 2011
eoSemi is an emerging privately-funded semiconductor product company based in South Yorkshire.Shrinking electronic systems are placing significant pressure on traditional timing and frequency devices to reduce in size without compromising performance - something they cannot do easily or cheaply.eoSemi is a new technological transformation.It meets head-on the challenges of size-vs-performance, with an enabling technology that allows for creation of far more compact designs, and that facilitates new classes of product and application. $4.5M / Jun 25, 2010
See all 16 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
South Korea
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Enterprise Ventures invest in?

Enterprise Ventures invests primarily in Biotechnology, Health Care and Medical startups, most often at Funding Round and Seed stage. Most of the 16 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Enterprise Ventures's check size?

Enterprise Ventures typically joins rounds of $524k–$5.1M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Enterprise Ventures participates in.

How do I contact Enterprise Ventures?

Public channels for Enterprise Ventures include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Enterprise Ventures?

The team at Enterprise Ventures includes Ashwin Kumaraswamy (Investment Manager), Clive Downward (Investment Director) and Grahame Lunt (Investment Manager), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Enterprise Ventures Enterprise Ventures Find emails